Andrea Tan
Stock Analyst at Goldman Sachs
(1.62)
# 3,459
Out of 5,106 analysts
49
Total ratings
44.74%
Success rate
-7.06%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Neutral | $27 → $48 | $70.09 | -31.52% | 2 | Nov 20, 2025 | |
| INSM Insmed | Maintains: Buy | $196 → $225 | $197.01 | +14.21% | 13 | Oct 31, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.20 | +263.64% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $81.35 | -37.31% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $8.36 | +222.97% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $6.23 | -3.69% | 5 | Jul 1, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $4.06 | -50.74% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $23.81 | -91.60% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $244.65 | -34.60% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $3.62 | +562.98% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.15 | +247.83% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $571.44 | -34.38% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $12.51 | +539.49% | 2 | May 24, 2022 |
Arrowhead Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $27 → $48
Current: $70.09
Upside: -31.52%
Insmed
Oct 31, 2025
Maintains: Buy
Price Target: $196 → $225
Current: $197.01
Upside: +14.21%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.20
Upside: +263.64%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $81.35
Upside: -37.31%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $8.36
Upside: +222.97%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $6.23
Upside: -3.69%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $4.06
Upside: -50.74%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $23.81
Upside: -91.60%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $244.65
Upside: -34.60%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $3.62
Upside: +562.98%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.15
Upside: +247.83%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $571.44
Upside: -34.38%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $12.51
Upside: +539.49%